To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Cancer and Dementia: Research
Monday 22nd April 2024

Asked by: Andrew Rosindell (Conservative - Romford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how much funding was provided for (a) dementia and (b) cancer research in the 2022-23 financial year.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

Government responsibility for delivering dementia research and dementia research funding is shared between the Department of Health and Social Care, with research delivered by the National Institute for Health and Care Research (NIHR), and the Department for Science Innovation and Technology, with research delivered via UK Research and Innovation.

In 2022/23, we estimate that total Government spend on dementia research was £99.9 million, with £35.1 million of this being via the NIHR. The Department of Health and Social Care spends £1.3 billion per year on health research through the NIHR. NIHR research expenditure for all cancers was £121.8 million in 2022/23, and the NIHR spends more on cancer than any other disease group.

The NIHR funds research in response to proposals received from scientists rather than allocating funding to specific disease areas. The NIHR welcomes funding applications for research into any aspect of human health, including all cancers and dementia types. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.


Written Question
Potatoes: Diseases
Monday 22nd April 2024

Asked by: Douglas Ross (Conservative - Moray)

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, what steps he is taking to help protect farmers against new strains of potato blight.

Answered by Mark Spencer - Minister of State (Department for Environment, Food and Rural Affairs)

Integrated Pest Management (IPM) is a holistic approach that carefully considers all available plant protection methods and keeps the use of pesticides to levels that are ecologically and economically justified. IPM lies at the heart of our approach to minimise the environmental impact of pesticides and is a key tool for businesses facing the challenges of pesticide resistance, removal of pesticides from the market, and changing pest pressures due to climate change. Within the National Action Plan for the Sustainable Use of Pesticides (NAP) we will set out our policies to increase the uptake of IPM by farmers, growers, amenity managers and amateur gardeners.

Having an IPM approach can reduce the risks associated with pesticides, combat pesticide resistance, and support sustainable agricultural productivity. IPM aims to diversify crop protection and reduce reliance on the use of chemical pesticides by making use of lower risk alternatives and promoting natural processes. For example, creating habitats for natural predators of plant pests, or using crop rotations to break pest, weed and disease cycles. When alternative methods are ineffective or unavailable, IPM also aims to optimise and minimise the use of chemical pesticides through targeted and precise application.

We have recently commissioned a package of research projects that will bring together scientific evidence underpinning IPM and to look at ways of further encouraging its uptake. This work will support farmers’ access to the most effective IPM tools available and ensure that we understand changing trends in pest threats across the UK.

Defra is also a partner in the European Research Area Network (ERA-Net) Co-Fund on Sustainable Crop Production (SusCrop). This research network aims to enhance cooperation and coordination of different national and regional research programmes focussing on agriculture and climate change, sustainable farming systems and biodiversity, sustainable water management, resource efficiency and resilience in the food chain. It also seeks to increase productivity through technological innovation.

Projects within SusCrop ERA-Net include: ‘Eco-friendly solutions for the integrated management of late and early blight of potatoes (ECOSOL)’ which aims to Identify Effective Biological Control Agents and Plant Resistance Inducers for the Control of Potato Late Blight in the field.


Written Question
Breast Cancer: Research
Monday 22nd April 2024

Asked by: Helen Hayes (Labour - Dulwich and West Norwood)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions her Department has had with the Department for Science, Innovation and Technology on funding for (a) the Lobular Moon Shot Project and (b) other research into lobular breast cancer.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department invests £1.3 billion per year into health research, with more spent on cancer than any other disease group, through the National Institute for Health and Care Research (NIHR). We work closely with UK Research and Innovation (UKRI) and the Medical Research Council (MRC), who are responsible for channelling a large proportion of the Department for Science, Innovation and Technology’s investments in this area. Our officials meet regularly to discuss a wide range of our investments, including into lobular and other breast cancers, to drive the maximum collective research impact on policy, practice, and individual lives. While research to understand the mechanisms of cancer, including lobular breast cancer, is largely funded through UKRI and the MRC, the NIHR invests in translational and implementation research to drive innovations into policy and practice.

Launched in 2023, the Lobular Moonshot Project is a high-level funding proposal and campaign to raise money to support the Institute for Cancer Research (ICR), with whom we meet regularly, to invest in fellowships and projects in lobular breast cancer. We are proud to have invested £29 million in the ICR and Royal Marsden NIHR Biological Research Centre in 2022, supporting their efforts to strengthen research into cancer, again including lobular breast cancer. This is complemented by wider investments into breast cancer research, for example, a £1.3 million project to determine whether an abbreviated form of breast magnetic resonance imaging can detect breast cancers missed by screening through mammography, such as lobular breast cancer. Our support to the NIHR Clinical Research Network has enabled the delivery of 10 further lobular breast-cancer related studies.

Additionally, the NIHR supports breast cancer research funded by research partners in the charity and public sectors through the NIHR’s Clinical Research Network (CRN). Over the last five years, the CRN has supported delivery of 10 lobular breast cancer-related studies conducted by other partners. While the NIHR cannot respond to direct solicitations for funding, instead commissioning on the basis of research excellence, we would welcome more applications from researchers on lobular breast cancer, including from the ICR. The NIHR funds research on cancer prevention, detection, diagnosis, treatment, and care, which saves lives.


Written Question
Breast Cancer: Research
Monday 22nd April 2024

Asked by: Helen Hayes (Labour - Dulwich and West Norwood)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she is taking steps to provide support to the Lobular Breast Cancer Project.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department invests £1.3 billion per year into health research, with more spent on cancer than any other disease group, through the National Institute for Health and Care Research (NIHR). We work closely with UK Research and Innovation (UKRI) and the Medical Research Council (MRC), who are responsible for channelling a large proportion of the Department for Science, Innovation and Technology’s investments in this area. Our officials meet regularly to discuss a wide range of our investments, including into lobular and other breast cancers, to drive the maximum collective research impact on policy, practice, and individual lives. While research to understand the mechanisms of cancer, including lobular breast cancer, is largely funded through UKRI and the MRC, the NIHR invests in translational and implementation research to drive innovations into policy and practice.

Launched in 2023, the Lobular Moonshot Project is a high-level funding proposal and campaign to raise money to support the Institute for Cancer Research (ICR), with whom we meet regularly, to invest in fellowships and projects in lobular breast cancer. We are proud to have invested £29 million in the ICR and Royal Marsden NIHR Biological Research Centre in 2022, supporting their efforts to strengthen research into cancer, again including lobular breast cancer. This is complemented by wider investments into breast cancer research, for example, a £1.3 million project to determine whether an abbreviated form of breast magnetic resonance imaging can detect breast cancers missed by screening through mammography, such as lobular breast cancer. Our support to the NIHR Clinical Research Network has enabled the delivery of 10 further lobular breast-cancer related studies.

Additionally, the NIHR supports breast cancer research funded by research partners in the charity and public sectors through the NIHR’s Clinical Research Network (CRN). Over the last five years, the CRN has supported delivery of 10 lobular breast cancer-related studies conducted by other partners. While the NIHR cannot respond to direct solicitations for funding, instead commissioning on the basis of research excellence, we would welcome more applications from researchers on lobular breast cancer, including from the ICR. The NIHR funds research on cancer prevention, detection, diagnosis, treatment, and care, which saves lives.


Written Question
Innovation and Research: Infrastructure
Thursday 18th April 2024

Asked by: Chi Onwurah (Labour - Newcastle upon Tyne Central)

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, with reference to the UK Science and Technology Framework, last updated on 9 February 2024, what her Department's planned timetable is for publishing the long-term national plan for research and innovation infrastructure.

Answered by Andrew Griffith - Minister of State (Department for Science, Innovation and Technology)

As per the S&T Framework update published in February, the government expects to publish a national plan for research and innovation infrastructure within 12 months.


Written Question
HyNet
Thursday 18th April 2024

Asked by: Caroline Lucas (Green Party - Brighton, Pavilion)

Question to the Department for Energy Security & Net Zero:

To ask the Secretary of State for Energy Security and Net Zero, whether her Department has committed (a) tax-payer and (b) tariff-backed guarantees to the North-West Hynet project.

Answered by Andrew Bowie - Parliamentary Under Secretary of State (Department for Energy Security and Net Zero)

The Government has announced up to £20 billion for the early deployment of CCUS in the UK and aims to establish four clusters by 2030, including the Track-1 HyNet cluster.

No contracts have yet been awarded through the Cluster Sequencing process. The form and amount of support provided to projects is subject to ongoing negotiations. Final decisions on whether to award support will be subject to achieving value for money outcomes for taxpayers and consumers.

To maximise participation, diversity, and resilience in the Cluster Sequencing process, we have also supported early-stage design work in industrial clusters, via the existing Industrial Decarbonisation Challenge Fund, which is run by UK Research and Innovation (UKRI). They announced the outcome of the challenge in 2021, committing up to £171m across nine projects, including £33m to projects in the HyNet cluster, crowding in private sector co-funding.


Written Question
Research: Gulf States
Thursday 18th April 2024

Asked by: Matthew Offord (Conservative - Hendon)

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, whether her Department is taking steps to help promote research links with Gulf States.

Answered by Andrew Griffith - Minister of State (Department for Science, Innovation and Technology)

As outlined in the Science and Technology Framework, global collaboration is vital in supporting UK science and technology capabilities and my department is working to strengthen strategic partnerships with governments, industry and academia across the globe. Partnerships will differ in scope and depth but given the strong economic growth and expanding populations of the Gulf States they represent an outsize opportunity to benefit the UK and strengthen our science and technology systems.

Consistent with this, last month, I signed a memorandum of understanding (MOU) on Research and Innovation (R&I) with Saudi Arabia – my first in the region - to help position the UK as a research and innovation partner of choice and create new opportunities for UK researchers and businesses.


Written Question
Solar Power: Manufacturing Industries
Thursday 18th April 2024

Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)

Question to the Department for Energy Security & Net Zero:

To ask the Secretary of State for Energy Security and Net Zero, what steps her Department (a) is taking and (b) plans to take to (i) support and (ii) enhance the domestic solar manufacturing sector.

Answered by Andrew Bowie - Parliamentary Under Secretary of State (Department for Energy Security and Net Zero)

Solar is a mature technology with established global supply chains. Whilst we have no plans for the UK to become self-sufficient in the manufacture of solar panels, supply chain development is a government priority.

Government encourages renewable developers accessing its Contracts for Difference scheme to grow the supply chain through the Supply Chain Plan process and supports supply chain innovation through the Energy Entrepreneurs Fund and initiatives funded by UK Research and Innovation.

Further actions needed to develop resilient, sustainable and innovative supply chains, as identified by the UK Solar Taskforce, will be outlined in the forthcoming Solar Roadmap.


Written Question
UK Research and Innovation: Colonialism
Thursday 18th April 2024

Asked by: John Hayes (Conservative - South Holland and The Deepings)

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, how many UK Research and Innovation projects have (a) titles and (b) subjects containing (i) decolonisation, (ii) colonialism, (iii) colonial and (iv) decolonising since 2019.

Answered by Andrew Griffith - Minister of State (Department for Science, Innovation and Technology)

These terms are used across a range of research areas and have different meanings, from the humanities and societal sciences, to biological sciences and microbial research.

The following data is sourced from Gateway to Research (https://gtr.ukri.org/), which supplies information about research and innovation projects and organisations funded by UKRI.

Of approximately 37,000 active projects initiated from 2019 onwards: 77 had titles referring to ‘Decolonisation/Decolonising’, 12 had titles referring to ‘Colonialism’ and 61 had titles mentioning the word ‘Colonial’.


Written Question
Disease Control: Research
Thursday 18th April 2024

Asked by: Chi Onwurah (Labour - Newcastle upon Tyne Central)

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, how much funding her Department has provided to support research into pandemic preparedness in the financial year 2023-24.

Answered by Andrew Griffith - Minister of State (Department for Science, Innovation and Technology)

DHSC are the lead department for pandemic preparedness, a core element of the UK Biological Security Strategy.